Search Results
52 items found for "Affiong Ika Oqua"
- 📰 GPCR Weekly News, May 6 to 12, 2024
Gutkind, and Francesco Raimondi for their work on The landscape of cancer-rewired GPCR signaling axes Affiong Ika Oqua, Dr.
- Label-free LC-MS based assay to characterize small molecule compound binding to cells
this assay was applied to an ion channel target with its agonists, of which the determined binding affinity
- Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of...
The observed differences in the binding affinity and cooperativity arise from the functional groups that membrane lipids as an integral component of transmembrane sites for accurate characterization, binding-affinity
- PI(4,5)P 2-stimulated positive feedback drives the recruitment of Dishevelled to Frizzled in Wnt-β-c
We found that the affinity of Fzd for Dvl was not affected by Wnt ligands, in contrast to other members of the GPCR superfamily for which the binding of extracellular ligands affects the affinity for downstream
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
these, four fragment- and seven lead-like compounds were confirmed to bind to the allosteric site with affinities The four compounds with the highest affinities were demonstrated to be negative allosteric modulators
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
these, four fragment- and seven lead-like compounds were confirmed to bind to the allosteric site with affinities The four compounds with the highest affinities were demonstrated to be negative allosteric modulators
- A new Kunitz-type snake toxin family associated with an original mode of interaction with the...
Key results: Eight additional MQs were identified with nanomolar affinities for the V2R, all antagonists The variant MQ1-K39A showed a higher affinity for the hV2R, but not for the rat V2R.
- Do You Believe AI Could Accelerate Drug Discovery?
They found that AF2 models achieved accurate side-chain predictions and successfully docked high-affinity The highest affinity compounds (15 to 24 nM) were identified from AF2 docking.
- GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
have been identified to exist in at least two distinct states: an active state characterized by high affinity for agonists when coupled to G proteins, and an inactive state in which their affinity for agonists discovery of allosteric modulators for GPCRs which possess the capability to modulate and fine-tune the affinity
- Nanobodies: New Dimensions in GPCR Signaling Research
Nb6B9: This is an affinity-matured nanobody derived from Nb80. Nb9-8: This nanobody was identified for the M2 muscarinic receptor (M2R) and increased the affinity of Nb39: This nanobody was identified for the μ-opioid receptor (μOR) and also increased the affinity of
- Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84
idiopathic pulmonary fibrosis are currently ongoing using ligands with differing levels of selectivity and affinity
- Targeting Intracellular Allosteric Sites in GPCRs
discovery of allosteric modulators for GPCRs which possess the capability to modulate and fine-tune the affinity classified as positive allosteric modulators (PAMs), which increase the receptor functional and/or affinity modulators targeting GPCRs can display one or more of the following pharmacological characteristics: 1) affinity
- Endogenous ligand recognition and structural transition of a human PTH receptor
PTH-bound and PTHrP-bound structures reveals distinct ligand-receptor interactions underlying the ligand affinity
- Endogenous ligand recognition and structural transition of a human PTH receptor
PTH-bound and PTHrP-bound structures reveals distinct ligand-receptor interactions underlying the ligand affinity
- The Adhesion GPCR VLGR1/ADGRV1 Regulates the Ca2+ Homeostasis at Mitochondria-Associated ER Membrane
Affinity proteomics revealed that in the interactome of VLGR1, molecules are enriched that are associated
- Lipid Modulation of a Class B GPCR: Elucidating the Modulatory Role of PI(4,5)P 2 Lipids
Specifically, we find the PI(4,5)P2 lipids to have a higher affinity toward the inactive conformation
- Mechanistic Understanding of the Palmitoylation of Go Protein in the Allosteric Regulation of...
allosterically stabilize the critical residues in the ligand-binding pocket of GPR97 and increase the affinity
- A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology in...
biosensor in membrane preparations and found that observed potency values better correlated with binding affinity
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
The directed evolution of ligand specificity in a GPCR and the unequal contributions of efficacy and affinity Extracellular loop 2 of the adenosine A1 receptor has a key role in orthosteric ligand affinity and agonist
- A Chemical Biology Toolbox Targeting the Intracellular Binding Site of CCR9: Fluorescent Ligands ...
cells, we discovered a 4-aminopyrimidine analogue as a new intracellular CCR9 antagonist with improved affinity
- Bell-Evans model and steered molecular dynamics in uncovering the dissociation kinetics of ligands..
times, which is a measure of drug efficacy in vivo, and simultaneously assessing computational binding affinities
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
genomically related transmembrane receptors, like C5aR1 (CD88, C5aR) and C5aR2 (GPR77, C5L2) with comparable affinity
- Glyco-sulfo hotspots in the chemokine receptor system
the negatively charged aminoacids and post-translational modifications (PTMs), contribute to the high affinity PTM has been shown to be heterogeneous [Li X et al. 2018; Scurci I et al. 2021) and to improve the affinity It has been also reported that PSGL-1 glycosulfo peptide analogue GSnP-6 displays nanomolar affinity
- In Vitro and In Silico Characterization of Kurarinone as a Dopamine D 1A Receptor Antagonist and ...
orthosteric binding pocket and the extracellular loops of D1R, D2LR, and D4R, validating substantial binding affinities
- On-cell nuclear magnetic resonance spectroscopy to probe cell surface interactions
These techniques allow for quantification of binding affinities, competitive binding assays, delineation
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
and virtual screening can efficiently analyze large databases of compounds and predict their binding affinity Paremeters such as ligand affinity for the receptor (pKi), the ability of a ligand to induce or inhibit novo drug design: AI algorithms can generate new molecules with desired properties, such as binding affinity
- Functional Characterization of the Venus Flytrap Domain of the Human TAS1R2 Sweet Taste Receptor
As expected, the ligand affinities of hTAS1R2-VFT were drastically reduced through the introduction of
- Novel interaction between neurotrophic factor-α1/carboxypeptidase E and serotonin receptor, 5-HTR1E,
interaction between NFα1/CPE and 5-HTR1E and 125I NF-α1/CPE-binding studies demonstrated saturable, high-affinity